open drug discovery
See the following -
Why Open Drug Discovery Needs Four Simple Rules For Licensing Data And Models
As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. Read More »
- Login to post comments
Open PHACTS Conference: Linking Life Science Data: Design to Implementation, and Beyond
Open PHACTS will be hosting a two-day conference in Vienna, Austria on the 18–19 February, 2016. The conference will include a variety of expert speakers and open discussions on linking data in the life sciences domain. Day 1 will focus on what has been achieved so far in this domain, by the Open PHACTS project and by others. Discussions will include an overview of how the domain has evolved, demonstrations of what can be done with existing linked data, and a poster competition where you can show off your own uses of linked life science data.
- Login to post comments